REQUEST A DEMO
Total
USD $0.00
Search more companies

A Plus Biotechnology Co., Ltd. (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: A Plus Biotechnology Co., Ltd. Profile Updated: July 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

A Plus Biotechnology Co., Ltd. is engaged in the manufacturing of the orthopedic implants. The company was established in 2009 and is headquartered in New Taipei City, Taiwan.

Headquarters
3F.,No.21 Qiaohe Rd, Zhonghe Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the A Plus Biotechnology Co., Ltd. report to view the information.

Website: http://www.aplubio.com

Basic Information
Total Employees:
Purchase the A Plus Biotechnology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the A Plus Biotechnology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the A Plus Biotechnology Co., Ltd. report to view the information.
Incorporation Date:
September 04, 2009
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
11.19%
Purchase this report to view the information.
5.93%
Purchase this report to view the information.
2.19%
Purchase this report to view the information.
1.31%
Purchase this report to view the information.
0.16%
Subsidiaries
A Plus(Cayman)Holding Inc. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after A Plus Biotechnology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
11.87%
Total operating revenue
12.71%
Operating profit (EBIT)
43.73%
EBITDA
34.34%
Net Profit (Loss) for the Period
53.58%
Total assets
0.74%
Total equity
-2.21%
Operating Profit Margin (ROS)
5.38%
Net Profit Margin
5.39%
Return on Equity (ROE)
3.04%
Debt to Equity Ratio
-0.85%
Quick Ratio
0.09%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?